Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.
Aberrant miRNA expression has been previously established in breast cancer and has clinical relevance. However, no studies so far have defined miRNAs deregulated in hereditary breast tumors. In this study we investigated the role of miRNAs in hereditary breast tumors comparing with normal breast tis...
Main Authors: | Miljana Tanic, Kira Yanowsky, Cristina Rodriguez-Antona, Raquel Andrés, Iván Márquez-Rodas, Ana Osorio, Javier Benitez, Beatriz Martinez-Delgado |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3372467?pdf=render |
Similar Items
-
Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription
by: Statham Aaron L, et al.
Published: (2011-01-01) -
miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors
by: Miljana Tanić, et al.
Published: (2015-03-01) -
Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
by: Annerieke Sierksma, et al.
Published: (2018-10-01) -
Deregulation of the miRNAs Expression in Cervical Cancer: Human Papillomavirus Implications
by: Yazmín Gómez-Gómez, et al.
Published: (2013-01-01) -
The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer
by: Xin eQin, et al.
Published: (2015-01-01)